ClearPoint Neuro, Inc. (CLPT)

Market Cap	269.05M -22.5%
Revenue (ttm)	36.97M +17.8%
Net Income	-25.54M
EPS	-0.90
Shares Out	29.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	374,055
Open	9.30
Previous Close	9.39
Day's Range	9.05 - 9.39
52-Week Range	8.63 - 30.10
Beta	1.07
Analysts	Strong Buy
Price Target	22.50 (+148.07%)
Earnings Date	Mar 17, 2026

About CLPT

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint softwa...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 172
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT
• Website: https://www.clearpointneuro.com

Financial Performance

In 2025, ClearPoint Neuro's revenue was $36.97 million, an increase of 17.78% compared to the previous year's $31.39 million. Losses were -$25.54 million, 35.0% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price target is $22.5, which is an increase of 148.07% from the latest price.

Price Target

$22.5

(148.07% upside)

Analyst Consensus: Strong Buy